Induction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stress |
| |
Authors: | Yang Ya-Chen Lii Chong-Kuei Lin Ai-Hsuan Yeh Yu-Wen Yao Hsien-Tsung Li Chien-Chun Liu Kai-Li Chen Haw-Wen |
| |
Affiliation: | Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan. |
| |
Abstract: | Butein and phloretin are chalcones that are members of the flavonoid family of polyphenols. Flavonoids have well-known antioxidant and anti-inflammatory activities. In rat primary hepatocytes, we examined whether butein and phloretin affect tert-butylhydroperoxide (tBHP)-induced oxidative damage and the possible mechanism(s) involved. Treatment with butein and phloretin markedly attenuated tBHP-induced peroxide formation, and this amelioration was reversed by l-buthionine-S-sulfoximine [a glutamate cysteine ligase (GCL) inhibitor] and zinc protoporphyrin [a heme oxygenase 1 (HO-1) inhibitor]. Butein and phloretin induced both HO-1 and GCL protein and mRNA expression and increased intracellular glutathione (GSH) and total GSH content. Butein treatment activated the ERK1/2 signaling pathway and increased Nrf2 nuclear translocation, Nrf2 nuclear protein-DNA binding activity, and ARE-luciferase reporter activity. The roles of the ERK signaling pathway and Nrf2 in butein-induced HO-1 and GCL catalytic subunit (GCLC) expression were determined by using RNA interference directed against ERK2 and Nrf2. Both siERK2 and siNrf2 abolished butein-induced HO-1 and GCLC protein expression. These results suggest the involvement of ERK2 and Nrf2 in the induction of HO-1 and GCLC by butein. In an animal study, phloretin was shown to increase GSH content and HO-1 expression in rat liver and decrease carbon tetrachloride-induced hepatotoxicity. In conclusion, we demonstrate that butein and phloretin up-regulate HO-1 and GCL expression through the ERK2/Nrf2 pathway and protect hepatocytes against oxidative stress. |
| |
Keywords: | ARE, antioxidant/electrophile response element BSO, smallcaps" >l-buthionine-S-sulfoximine CVD, cardiovascular disease EMSA, electrophoretic mobility-shift assay ERK, extracellular signal-regulated kinase GAPDH, glyceraldehyde-3-phosphate dehydrogenase GCL, glutamate cysteine ligase GCLC, glutamate cysteine ligase catalytic subunit GOT, glutamic oxaloacetic transaminase GPT, glutamic pyruvic transaminase GSH, glutathione HO-1, heme oxygenase 1 ITS+, insulin, transferrin, selenium, bovine serum albumin, and linoleic acid Keap1, Kelch-like ECH-associated protein 1 MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Nrf2, nuclear factor erythroid 2-related 2 siRNA, small interfering RNA tBHP, tert-butylhydroperoxide ZnPP, zinc protoporphyrin |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|